Amendments to the Fair Value Option (IAS 28) Active Exposure draft consultation Vincent Papa Sapna Heeralall Menu: Project phase Description Documents Meeting documents Meetings Projects news (-) All news Financial Reporting Invitation to comment Facet Department Date ascendingDate descending Financial Reporting 16.04.2026 EFRAG publishes Final Comment Letter on the IAS 28 Fair Value Option Exposure Draft and supports the IASB’s proposals Read EFRAG’s final comment letter on IASB Exposure Draft on the IAS 28 Fair Value Option for Investments in Associates and Joint Venture Read more about EFRAG publishes Final Comment Letter on the IAS 28 Fair Value Option Exposure Draft and supports the IASB’s proposals Invitation to comment 27.02.2026 EFRAG releases Draft Comment Letter on IASB´s Proposed amendments to IAS 28 on the Fair Value Option for Investments in Associates and Joint Ventures Stakeholders are invited to provide feedback on EFRAG's Draft Comment Letter by 7 April. Read more about EFRAG releases Draft Comment Letter on IASB´s Proposed amendments to IAS 28 on the Fair Value Option for Investments in Associates and Joint Ventures
Amendments to the Fair Value Option (IAS 28) Active Exposure draft consultation Vincent Papa Sapna Heeralall
Financial Reporting 16.04.2026 EFRAG publishes Final Comment Letter on the IAS 28 Fair Value Option Exposure Draft and supports the IASB’s proposals Read EFRAG’s final comment letter on IASB Exposure Draft on the IAS 28 Fair Value Option for Investments in Associates and Joint Venture Read more about EFRAG publishes Final Comment Letter on the IAS 28 Fair Value Option Exposure Draft and supports the IASB’s proposals
Invitation to comment 27.02.2026 EFRAG releases Draft Comment Letter on IASB´s Proposed amendments to IAS 28 on the Fair Value Option for Investments in Associates and Joint Ventures Stakeholders are invited to provide feedback on EFRAG's Draft Comment Letter by 7 April. Read more about EFRAG releases Draft Comment Letter on IASB´s Proposed amendments to IAS 28 on the Fair Value Option for Investments in Associates and Joint Ventures
